66 related articles for article (PubMed ID: 19003570)
41. Catalytic Hydrogenolysis of Polyolefins into Alkanes.
Sánchez-Rivera KL; Huber GW
ACS Cent Sci; 2021 Jan; 7(1):17-19. PubMed ID: 33532565
[No Abstract] [Full Text] [Related]
42. Antiviral Activity of Uridine Derivatives of 2-Deoxy Sugars against Tick-Borne Encephalitis Virus.
Krol E; Wandzik I; Brzuska G; Eyer L; Růžek D; Szewczyk B
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901934
[TBL] [Abstract][Full Text] [Related]
43. Anti-Hepatitis C Virus Activity of Uridine Derivatives of 2-Deoxy Sugars.
Krol E; Wandzik I; Pastuch-Gawolek G; Szewczyk B
Molecules; 2018 Jun; 23(7):. PubMed ID: 29954068
[TBL] [Abstract][Full Text] [Related]
44. Biological Evaluation of Uridine Derivatives of 2-Deoxy Sugars as Potential Antiviral Compounds against Influenza A Virus.
Krol E; Wandzik I; Krejmer-Rabalska M; Szewczyk B
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777309
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and preliminary biological evaluations of 5'-substituted derivatives of uridine as glycosyltransferase inhibitors.
Paszkowska J; Kral K; Bieg T; Nawrot U; Szeja W; Wandzik I
Molecules; 2013 Jul; 18(7):8018-27. PubMed ID: 23884133
[TBL] [Abstract][Full Text] [Related]
46. Efficient synthesis of nucleoside aryloxy phosphoramidate prodrugs utilizing benzyloxycarbonyl protection.
Cho JH; Amblard F; Coats SJ; Schinazi RF
Tetrahedron; 2011 Jul; 67(30):5487-5493. PubMed ID: 22993455
[TBL] [Abstract][Full Text] [Related]
47. Efficient synthesis of exo-N-carbamoyl nucleosides: application to the synthesis of phosphoramidate prodrugs.
Cho JH; Coats SJ; Schinazi RF
Org Lett; 2012 May; 14(10):2488-91. PubMed ID: 22554490
[TBL] [Abstract][Full Text] [Related]
48. [Development of a novel type of Pd/C-catalyzed chemoselective hydrogenation using a nitrogen catalyst poison].
Sajiki H
Yakugaku Zasshi; 2000 Nov; 120(11):1091-103. PubMed ID: 11190196
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneous catalytic hydrogenation reactions in continuous-flow reactors.
Irfan M; Glasnov TN; Kappe CO
ChemSusChem; 2011 Mar; 4(3):300-16. PubMed ID: 21337528
[TBL] [Abstract][Full Text] [Related]
50. Facile deprotection of O-Cbz-protected nucleosides by hydrogenolysis: an alternative to O-benzyl ether-protected nucleosides.
Johnson DC; Widlanski TS
Org Lett; 2004 Dec; 6(25):4643-6. PubMed ID: 15575650
[TBL] [Abstract][Full Text] [Related]
51. Catalytic hydrogenolysis in liquid ammonia. Cleavage of Nalpha-benzyloxycarbonyl groups from cysteine-containing peptides with tert-butyl side chain protection. Application to a stepwise synthesis of somatostatin.
Felix AM; Jimenez MH; Mowles T; Meienhofer J
Int J Pept Protein Res; 1978 May; 11(5):329-39. PubMed ID: 681077
[TBL] [Abstract][Full Text] [Related]
52. Golgi endomannosidase inhibitor, alpha-D-glucopyranosyl-(1 --> 3)-1-deoxymannojirimycin: a five-step synthesis from maltulose and examples of N-modified derivatives.
Spreitz J; Stütz AE
Carbohydr Res; 2004 Jul; 339(10):1823-7. PubMed ID: 15220094
[TBL] [Abstract][Full Text] [Related]
53. Practical synthesis of (2'R)-2'-deoxy-2'-C-methyluridine by highly diastereoselective homogeneous hydrogenation.
Lemaire S; Houpis I; Wechselberger R; Langens J; Vermeulen WA; Smets N; Nettekoven U; Wang Y; Xiao T; Qu H; Liu R; Jonckers TH; Raboisson P; Vandyck K; Nilsson KM; Farina V
J Org Chem; 2011 Jan; 76(1):297-300. PubMed ID: 21133352
[TBL] [Abstract][Full Text] [Related]
54. Removal of the N alpha-benzyloxycarbonyl group from cysteine-containing peptides by catalytic hydrogenolysis in liquid ammonia, exemplified by a synthesis of oxytocin.
Kuromizu K; Meienhofer J
J Am Chem Soc; 1974 Jul; 96(15):4978-81. PubMed ID: 4854100
[No Abstract] [Full Text] [Related]
55. Simultaneous removal of benzyl and benzyloxycarbonyl protective groups in 5'-O-(2-deoxy-alpha-D-glucopyranosyl)uridine by catalytic transfer hydrogenolysis.
Wandzik I; Bieg T; Kadela M
Nucleosides Nucleotides Nucleic Acids; 2008 Dec; 27(12):1250-6. PubMed ID: 19003570
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
